Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Hervé Farine"'
Autor:
Peter Blattmann, Hervé Farine, Brian Dan, Nicole Stiffler, Thomas Lefebvre, Christine Huynh, Patricia N. Sidharta, Jasper Dingemanse, Richard W. D. Welford, Marcel Keller, Daniel S. Strasser
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 2, Pp n/a-n/a (2024)
Abstract CXCL12 acts as a chemoattractant by binding to the receptor CXCR4. The (atypical) chemokine receptor ACKR3 (CXCR7) scavenges CXCL12. Antagonism of ACKR3 thus leads to an increase in CXCL12 concentrations that has been used as a pharmacodynam
Externí odkaz:
https://doaj.org/article/e53b8c21584147f092daf12cfbcb0485
Autor:
Marion Anliker‐Ort, Jasper Dingemanse, Hervé Farine, Peter Groenen, Rüdiger Kornberger, John van den Anker, Priska Kaufmann
Publikováno v:
British Journal of Clinical Pharmacology. 89:380-389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f77b626426fc21210ecedd2bada9d1d
https://doi.org/10.1111/bcp.15508
https://doi.org/10.1111/bcp.15508
Autor:
Julia Marrie, Enrico Vezzali, Anna Sassi, Nadège Baumlin, Ulrich Mentzel, Marianne M. Martinic, Hervé Farine, Laetitia Pouzol, Mélanie Tunis
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyREFERENCES. 35(3)
Current strategies for the treatment of demyelinating diseases such as multiple sclerosis (MS) are based on anti-inflammatory or immunomodulatory drugs. Those drugs have the potential to reduce the frequency of new lesions but do not directly promote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e819310d260210ebd29041c83b27c5ed
https://pubmed.ncbi.nlm.nih.gov/33595155
https://pubmed.ncbi.nlm.nih.gov/33595155
Autor:
Richard W. D. Welford, Agata Sebastian, Alexander Schmidt, Daniel S. Strasser, Marcel P Keller, Lukasz Kozera, Hervé Farine
Publikováno v:
Journal of proteome research. 19(10)
One of the most important advantages of mass spectrometry is the ability to quantify proteins and their modifications in parallel to obtain a holistic picture of the protein of interest. Here, we present a hybrid immunoaffinity targeted mass spectrom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4589d965be456cc06c50c279810f851
https://pubmed.ncbi.nlm.nih.gov/32870689
https://pubmed.ncbi.nlm.nih.gov/32870689
Autor:
Marten Trendelenburg, Andrea Kieninger-Graefitsch, Gabin M Pierlot, Marcel P Keller, Daniel S. Strasser, Estelle Gerossier, Marianne M Martinic, Sylvie Froidevaux, Virginie Sippel, Paulina Kulig, Ursula Grieder, Hervé Farine, Mark Murphy
Publikováno v:
Poster presentations.
Background Reported here is the characterization of cenerimod, a novel, potent, selective, and orally active sphingosine-1-phosphate receptor 1 (S1P1) modulator in the context of SLE. Methods Lymphocytes from patients with SLE and healthy subjects we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9b1f33c5c9da3ebf5c1fe7cfa984903
https://doi.org/10.1136/lupus-2020-eurolupus.182
https://doi.org/10.1136/lupus-2020-eurolupus.182
Autor:
Daniel S Strasser, Estelle Gerossier, Virginie Sippel, Ursula Grieder, Andrea Kieninger-Graefitsch, Gabin Pierlot, Hervé Farine, Paulina Kulig, Marcel Keller, Sylvie Froidevaux, Marten Trendelenburg, Mark Murphy, Marianne Martinic
Publikováno v:
Oral presentations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4befd8435ec8372ff097a1324a1f8c74
https://doi.org/10.1136/lupus-2020-eurolupus.49
https://doi.org/10.1136/lupus-2020-eurolupus.49
Autor:
Hervé Farine, Nonhlanhla Lunjani, Peter M.A. Groenen, Eugen Bersuch, Juliane Schreiber, Andrew L. Croxford, Ge Tan, Petr Kubena, Mübeccel Akdis, Anita Dreher, Tadech Boonpiyathad, Beate Rückert, Daniel S. Strasser, Pattraporn Satitsuksanoa, Martine Clozel, HW Duchna, Gertruda Capova, Cezmi A. Akdis, David Mirer, Ellen D. Renner
Publikováno v:
Allergy 75, 84-94 (2019)
Background Asthma patients present with distinct immunological profiles, with a predominance of type 2 endotype. The aim of this study was to investigate the impact of high‐altitude treatment on the clinical and immunological response in asthma. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d1cd92fc91d0934c220ed40a6d8c3a
https://pubmed.ncbi.nlm.nih.gov/33020860
https://pubmed.ncbi.nlm.nih.gov/33020860
Autor:
Dominik Lott, Patricia N. Sidharta, Hervé Farine, Martine Gehin, Milena Issac, Jasper Dingemanse, Daniel S. Strasser
Publikováno v:
Basicclinical pharmacologytoxicology. 124(6)
ACT-774312 is an antagonist of the chemoattractant receptor-homologous molecule expressed on T helper (Th) 2 cells (CRTH2), in development for the treatment of nasal polyposis or other allergic and type-2 inflammatory diseases. Placebo, single doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0334b6f30f87c36609f4e4eb785d5f00
https://pubmed.ncbi.nlm.nih.gov/30589994
https://pubmed.ncbi.nlm.nih.gov/30589994
Autor:
Hervé Farine, Julie Hoerner, Peter M.A. Groenen, Daniel S. Strasser, Martin Holdener, Patricia N. Sidharta, Martine Gehin, Jasper Dingemanse, René Roscher, Jochen Zisowsky
Publikováno v:
European Journal of Molecular and Clinical Medicine, Vol 2, Iss 4-5, Pp 118-125 (2015)
Biomarkers have shown to improve success rates in the development of novel drugs, providing essential information in the early phases of clinical development for decision-making. Chemoattractant receptor-homologous molecule expressed on Th2 cells (CR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b4f17496e233b4a4886b9d53b46b88
https://www.ejmcm.com/articles/210
https://www.ejmcm.com/articles/210